Infratil $480m injection prevents CDC devaluation
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Alan Bollard: Fonterra Sale: Good for farmers, what about NZ?
Winston Peters was right to query the sale of Fonterra’s consumer brands.
Big names for Wellington Water board
Credit rating agency warns that water reforms are no council debt panacea.
Green light for solar farm near Greytown, Wairarapa
Far North Solar Farm and the local council still need to work out conditions.
NZ risks losing edge as Australia takes lead in cleaner jet fuel
Experts warn SAF delay could cost jobs and growth.
